
The main office of represented VC is situated in the Changning. The fund was located in Asia if to be more exact in China.
The typical case for the fund is to invest in rounds with 1-2 participants. Despite the HY Capital, startups are often financed by Zimi Fund, Lotus Lake Ventures, Agricultural Fund of China. The meaningful sponsors for the fund in investment in the same round are LYFE Capital, Fortune Venture Capital, Crystal Pharmatech. In the next rounds fund is usually obtained by Fortune Venture Capital.
Besides them, we counted 2 critical employees of this fund in our database.
Speaking about the real fund results, this VC is 51 percentage points more often commits exit comparing to other organizations. The important activity for fund was in 2018. The fund is constantly included in 2-6 deals per year. The usual things for fund are deals in the range of 10 - 50 millions dollars.
We can highlight the next thriving fund investment areas, such as Rental, E-Commerce. The fund has no exact preference in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most popular portfolio startups of the fund, we may highlight Zhizu Tech, Cloudbreak Therapeutics, Symbow Medical, Ltd.. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
Related Funds
Funds with similar focus
Fund Name | Location |
1Can Network | - |
Alloy Online | New York, New York, United States |
Anniston Capital | New York, New York, United States |
Banca Etica | - |
Caltrop | California, Riverside, United States |
Energia Ventures | Canada, Fredericton, New Brunswick |
Fluid Vehicle Owners | - |
G7 | Beijing, Beijing, China |
Howbuy | China, Shanghai |
Initiative Capital Romandie | - |
Jinx Development, LLC | - |
Montiko GmbH | Baden-Wurttemberg, Germany, Karlsruhe |
Prime Holdings | - |
Qianhe Capital | Beijing, Beijing, China |
Shenzhen Qianhai Rengong Zhineng Liuhao Touzi | China, Guangdong, Shenzhen |
Space Expedition Corporation (SXC) | Amsterdam, Noord-Holland, The Netherlands |
UST | Aliso Viejo, California, United States |
Wellspring Investments | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Chinagene Tech | $15M | 30 Mar 2022 | Changping District, Beijing, China | ||
Yijian Health | 11 Jan 2022 | Shanghai, Shanghai, China | |||
$14M | 21 Apr 2020 | China, Beijing | |||
Zhizu Tech | $15M | 21 Aug 2019 | Shanghai, China | ||
30 May 2019 | Yuexiu District, Guangdong Province | ||||
Cloudbreak Therapeutics | $15M | 26 Oct 2018 | Irvine, California, United States | ||
26 Sep 2018 | Shanghai | ||||
25 Apr 2018 | Shanghai | ||||
Laviana Pharma | $15M | 02 Jan 2018 | Beijing |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Chinagene Tech | $15M | 30 Mar 2022 | Changping District, Beijing, China | ||
Yijian Health | 11 Jan 2022 | Shanghai, Shanghai, China | |||
$14M | 21 Apr 2020 | China, Beijing | |||
Zhizu Tech | $15M | 21 Aug 2019 | Shanghai, China | ||
30 May 2019 | Yuexiu District, Guangdong Province | ||||
Cloudbreak Therapeutics | $15M | 26 Oct 2018 | Irvine, California, United States | ||
26 Sep 2018 | Shanghai | ||||
25 Apr 2018 | Shanghai | ||||
Laviana Pharma | $15M | 02 Jan 2018 | Beijing |